NCT03971695View on ClinicalTrials.gov

A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

December 4, 2020

Study Completion Date

December 4, 2020

Conditions
Healthy
Interventions
DRUG

BI 706321

Capsule or Oral Solution

DRUG

Placebo

Capsule or Oral solution

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03971695 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321 | Biotech Hunter | Biotech Hunter